Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.

Celldex Therapeutics, Inc.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Owlet (OWLT), Celldex (CLDX) and Edgewise Therapeu...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Owlet (OWLT), Celldex (CLDX) and Edgewise Therapeutics (EWTX)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Merck & Company (MRK), Celldex (CLDX) and Inventiv...

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Celldex (CLDX) and Inventiva (IVA)

Wells Fargo analyst Derek Archila maintained a Buy rating on Celldex yesterday and set a price target of $72.00. The company’s shares closed yester...

Wells Fargo Keeps Their Buy Rating on Celldex (CLDX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pfizer (PFE), Celldex (CLDX) and Vertex Pharmaceuticals (VRTX). P...

Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Celldex (CLDX) and Vertex Pharmaceuticals (VRTX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immunic (IMUX), Celldex (CLDX) and Cooper Co (COO) w...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CLDX	$31.48	+1.16%	2.29M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CLDX	$31.48	+1.2%	2.29M
3
4
5
6

CLDX

Get Celldex Therapeutics, Inc. Data in Excel

Get Celldex Therapeutics, Inc. Data in Excel